US 12391760
Method of treating primary sclerosing cholangitis
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 12391760 (Method of treating primary sclerosing cholangitis) held by Takeda Pharmaceutical Company Limited expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K39/39533